Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches.

Adamopoulos PG, Tsiakanikas P, Kontos CK, Panagiotou A, Vassilacopoulou D, Scorilas A.

Gene. 2019 Nov 30;719:144075. doi: 10.1016/j.gene.2019.144075. Epub 2019 Aug 23.

PMID:
31449843
2.

Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections.

Frakolaki E, Kalliampakou KI, Kaimou P, Moraiti M, Kolaitis N, Boleti H, Koskinas J, Vassilacopoulou D, Vassilaki N.

Cells. 2019 Aug 5;8(8). pii: E837. doi: 10.3390/cells8080837.

3.

Mobile phone electromagnetic radiation affects Amyloid Precursor Protein and α-synuclein metabolism in SH-SY5Y cells.

Stefi AL, Margaritis LH, Skouroliakou AS, Vassilacopoulou D.

Pathophysiology. 2019 Mar 1. pii: S0928-4680(18)30352-3. doi: 10.1016/j.pathophys.2019.02.004. [Epub ahead of print]

PMID:
30850244
4.

L-Dopa decarboxylase interaction with the major signaling regulator ΡΙ3Κ in tissues and cells of neural and peripheral origin.

Vassiliou AG, Siaterli MZ, Frakolaki E, Gkogkosi P, Paspaltsis I, Sklaviadis T, Vassilacopoulou D, Vassilaki N.

Biochimie. 2019 May;160:76-87. doi: 10.1016/j.biochi.2019.02.009. Epub 2019 Feb 20.

PMID:
30796964
5.

The Role of Tissue Oxygen Tension in Dengue Virus Replication.

Frakolaki E, Kaimou P, Moraiti M, Kalliampakou KI, Karampetsou K, Dotsika E, Liakos P, Vassilacopoulou D, Mavromara P, Bartenschlager R, Vassilaki N.

Cells. 2018 Dec 1;7(12). pii: E241. doi: 10.3390/cells7120241.

6.

Molecular Effects of Treatment of Human Colorectal Cancer Cells with Natural and Classical Chemotherapeutic Drugs: Alterations in the Expression of Apoptosis-related BCL2 Family Members, Including BCL2L12.

Kontos CK, Avgeris M, Vassilacopoulou D, Ardavanis A, Scorilas A.

Curr Pharm Biotechnol. 2018;19(13):1064-1075. doi: 10.2174/1389201019666181112101410.

PMID:
30417787
7.

Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone.

Kalantzis ED, Scorilas A, Vassilacopoulou D.

Curr Pharm Biotechnol. 2018;19(13):1087-1096. doi: 10.2174/1389201019666181112103637.

PMID:
30417785
8.

Release of membrane-associated L-dopa decarboxylase from human cells.

Chalatsa I, Fragoulis EG, Vassilacopoulou D.

Neurochem Res. 2011 Aug;36(8):1426-34. doi: 10.1007/s11064-011-0468-4. Epub 2011 Apr 11.

PMID:
21479916
9.

L-Dopa decarboxylase expression profile in human cancer cells.

Chalatsa I, Nikolouzou E, Fragoulis EG, Vassilacopoulou D.

Mol Biol Rep. 2011 Feb;38(2):1005-11. doi: 10.1007/s11033-010-0196-x. Epub 2010 Jun 11.

PMID:
20535562
10.

The U937 macrophage cell line expresses enzymatically active L-Dopa decarboxylase.

Kokkinou I, Fragoulis EG, Vassilacopoulou D.

J Neuroimmunol. 2009 Nov 30;216(1-2):51-8. doi: 10.1016/j.jneuroim.2009.09.001. Epub 2009 Oct 1.

PMID:
19800137
11.

Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes.

Kokkinou I, Nikolouzou E, Hatzimanolis A, Fragoulis EG, Vassilacopoulou D.

Blood Cells Mol Dis. 2009 Jan-Feb;42(1):92-8. doi: 10.1016/j.bcmd.2008.10.010. Epub 2008 Nov 28.

PMID:
19041269
12.

Detection, purification and identification of an endogenous inhibitor of L-Dopa decarboxylase activity from human placenta.

Vassiliou AG, Fragoulis EG, Vassilacopoulou D.

Neurochem Res. 2009 Jun;34(6):1089-100. doi: 10.1007/s11064-008-9879-2. Epub 2008 Nov 13.

PMID:
19005753
13.

Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum.

Vassiliou AG, Vassilacopoulou D, Fragoulis EG.

Neurochem Res. 2005 May;30(5):641-9.

PMID:
16176068
14.

Identification and characterization of a novel form of the human L-dopa decarboxylase mRNA.

Vassilacopoulou D, Sideris DC, Vassiliou AG, Fragoulis EG.

Neurochem Res. 2004 Oct;29(10):1817-23.

PMID:
15532536
15.

Cloning and expression of human placental L-Dopa decarboxylase.

Siaterli MZ, Vassilacopoulou D, Fragoulis EG.

Neurochem Res. 2003 Jun;28(6):797-803.

PMID:
12718431
16.

L-DOPA decarboxylase association with membranes in mouse brain.

Poulikakos P, Vassilacopoulou D, Fragoulis EG.

Neurochem Res. 2001 May;26(5):479-85.

PMID:
11513473
17.

The BC200 RNA gene and its neural expression are conserved in Anthropoidea (Primates).

Skryabin BV, Kremerskothen J, Vassilacopoulou D, Disotell TR, Kapitonov VV, Jurka J, Brosius J.

J Mol Evol. 1998 Dec;47(6):677-85.

PMID:
9847409
18.

Release of nontransmembrane full-length Alzheimer's amyloid precursor protein from the lumenar surface of chromaffin granule membranes.

Tezapsidis N, Li HC, Ripellino JA, Efthimiopoulos S, Vassilacopoulou D, Sambamurti K, Toneff T, Yasothornsrikul S, Hook VY, Robakis NK.

Biochemistry. 1998 Feb 3;37(5):1274-82.

PMID:
9477953
19.

Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells.

Efthimiopoulos S, Vassilacopoulou D, Ripellino JA, Tezapsidis N, Robakis NK.

Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8046-50.

20.

The Alzheimer amyloid precursor proteoglycan (appican) is present in brain and is produced by astrocytes but not by neurons in primary neural cultures.

Shioi J, Pangalos MN, Ripellino JA, Vassilacopoulou D, Mytilineou C, Margolis RU, Robakis NK.

J Biol Chem. 1995 May 19;270(20):11839-44.

Supplemental Content

Loading ...
Support Center